Evidence map›Paper›PMID 40027071›Full record

ArticleKidney medicine2025

Kidney Function in the Wixarika (Huichol) Ethnic Group, a Disadvantaged Population Underevaluated in Mexico.

Betsabe Contreras-Haro, Norma G González-Montoya, Alfonso M Cueto-Manzano, Ana M Saldaña-Cruz, Fabiola Martin-Del Campo, Oswaldo Zamora-González, Enrique Rojas-Campos, Jazmín Márquez-Pedroza, Sergio Gallardo-Moya, Norma A Rodríguez-Jiménez

Abstract read
In one paragraph

Article in Kidney medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Betsabe Contreras-HaroBiomedical Research Unit 02, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico.
Norma G González-MontoyaNorth University Center (CUNORTE), University of Guadalajara, Colotlan, Jalisco, Mexico.
Alfonso M Cueto-ManzanoBiomedical Research Unit 02, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico.
Ana M Saldaña-CruzInstitute of Experimental and Clinical Therapeutics, University Center for Health Sciences (CUCS), University of Guadalajara, Guadalajara, Jalisco, Mexico.
Fabiola Martin-Del CampoBiomedical Research Unit 02, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico.
Oswaldo Zamora-GonzálezNorth University Center (CUNORTE), University of Guadalajara, Colotlan, Jalisco, Mexico.
Enrique Rojas-CamposBiomedical Research Unit 02, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico.
Jazmín Márquez-PedrozaNeurosciences Division, Western Biomedical Research Center (CIBO), Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico.
Sergio Gallardo-MoyaInstitute of Experimental and Clinical Therapeutics, University Center for Health Sciences (CUCS), University of Guadalajara, Guadalajara, Jalisco, Mexico.
Norma A Rodríguez-JiménezNeurosciences Division, Western Biomedical Research Center (CIBO), Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chronic kidney diseaseHuichol Indianskidney functionvulnerable population

Identifiers

PMID40027071
PMCPMC11867516

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.